Skip to content

Advertisement

Article highlight: Molecular biomarkers in gastro-esophageal cancer

New Content ItemSignificant progress has been made in recent years in dissecting the genomic makeup of gastro-esophageal adenocarcinomas (GEA), which have been found to be highly heterogeneous malignances, representing a challenge for biomarkers discovery and targeted treatment development. This invited review, by Drs Battaglin, Naseem, Puccini & Lenz focuses on an overview of established and novel promising biomarkers in GEA, covering recent molecular classifications from TCGA and ACRG. The review appears in Emerging biomarkers in oncology research and practice, guest edited by Dr. Aejaz Nasir.

Articles

Most accessed articles RSS

View all articles

Aims and scope

Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques.

Read more

Editors-in-Chief

Y Eugene Chin, Shanghai Institute of Biological Sciences, China
Domenico Coppola, Moffitt Cancer Center, USA

Associate Editor spotlight

Matteo FassanMarilin Rosa

Dr. Marilin Rosa specializes in Breast Pathology and Cytopathology and serves as the Section Head of Breast Pathology at Moffitt Cancer Center and Research Institute in Tampa, Florida, USA. Dr. Rosa is also program director of the Breast Pathology Fellowship program at Moffitt. Her expertise is in breast cancer diagnosis, research, and education. Dr. Rosa’s research interests are identifying diagnostic, prognostic, and predictive biomarkers for breast cancer as well as studying cancer impact in low-resource/ minority populations.

Editorial Board spotlight

Sritama NathGo J. Yoshida

Dr. Go J. Yoshida graduated from Keio University School of Medicine in 2010 and obtained his PhD in 2013 with research on redox stress regulation in gastric and breast cancer stem cells through CD44 variant-xCT interaction. Since 2014, he has been working mainly on the pathophysiological significance of autophagy at the Medical Research Institute, Tokyo Medical and Dental University. He has recently reported the therapeutic potential of autophagic cell death in glioblastoma stem cells.

Advertisement

2017 Journal Metrics

Advertisement